ChemSpider 2D Image | Pepto-Bismol | C7H5BiO4

Pepto-Bismol

  • Molecular FormulaC7H5BiO4
  • Average mass362.093 Da
  • Monoisotopic mass361.999176 Da
  • ChemSpider ID17215772

  • Charge - Charge

More details:

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

14882-18-9 [RN]
238-953-1 [EINECS]
2-Hydroxy-4H-1,3,2-benzodioxabismin-4-on [German] [ACD/IUPAC Name]
2-Hydroxy-4H-1,3,2-benzodioxabismin-4-one [ACD/IUPAC Name]
2-Hydroxy-4H-1,3,2-benzodioxabismin-4-one [French] [ACD/IUPAC Name]
2-hydroxy-4H-benzo[d][1,3,2]dioxabismin-4-one
4H-1,3,2-Benzodioxabismin-4-one, 2-hydroxy- [ACD/Index Name]
Bismuth oxide salicylate
Bismuth oxysalicylate
Bismuth Subsalicylate
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

9170211 [DBID]
480789_ALDRICH [DBID]
62TEY51RR1 [DBID]
80267_FLUKA [DBID]
95386_FLUKA [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous

    • Safety:

      WARNING: Causes GI injury, skin and eye irritation Alfa Aesar 40395

    • Chemical Class:

      A bismuth salt of salicylic acid. ChEBI https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:261649, CHEBI:261649

    • Bio Activity:

      Bismuth Subsalicylate is the active ingredient in Pepto-Bismol and inhibits prostaglandin G/H Synthase 1/2. MedChem Express
      Bismuth Subsalicylate is the active ingredient in Pepto-Bismol and inhibits prostaglandin G/H Synthase 1/2.; Target: Others; Bismuth Subsalicylate reduces inflammation/irritation of stomach and intestinal lining through inhibition of prostaglandin G/H Synthase 1/2 [1]. MedChem Express HY-B0550
      Bismuth Subsalicylate is the active ingredient in Pepto-Bismol and inhibits prostaglandin G/H Synthase 1/2.;Target: Bismuth Subsalicylate reduces inflammation/irritation of stomach and intestinal lining through inhibition of prostaglandin G/H Synthase 1/2 [1]. Bismuth Subsalicylate is the active ingredient in Pepto-Bismol, an anti-diarrhea medication and antacid. In the gastrointestinal tract, Bismuth Subsalicylate is converted to salicylic acid and insoluble bismuth salts [2]. Bismuth subsalicylate treatment for 8 weeks is safe and well tolerated. This regimen appears to be efficacious for the treatment of microscopic colitis and is worthy of further study in a controlled trial [3]. MedChem Express HY-B0550
      Others MedChem Express HY-B0550

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module, version: 14.00

Density:
Boiling Point:
Vapour Pressure:
Enthalpy of Vaporization:
Flash Point:
Index of Refraction:
Molar Refractivity:
#H bond acceptors: 4
#H bond donors: 1
#Freely Rotating Bonds: 0
#Rule of 5 Violations:
ACD/LogP:
ACD/LogD (pH 5.5):
ACD/BCF (pH 5.5):
ACD/KOC (pH 5.5):
ACD/LogD (pH 7.4):
ACD/BCF (pH 7.4):
ACD/KOC (pH 7.4):
Polar Surface Area: 56 Å2
Polarizability:
Surface Tension:
Molar Volume:

Click to predict properties on the Chemicalize site


Advertisement